National Egyptian HLH Registry for pediatric patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational effort aims to establish a centralized registry for HLH cases in Egypt, led by Ain Shams University. The registry will compile demographic, clinical, and outcome data from participating centers to describe how HLH presents and is managed in the Egyptian pediatric population. No interventional procedures are involved; the study focuses on data collection and sharing to support future research and quality improvement. Sites include the Faculty of Medicine Pediatric Hematology Oncology Department in Cairo and Ain Shams University, with no listed collaborators. Participation is limited to patients diagnosed with HLH, excluding adults.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients diagnosed with hlh

Exclusion Criteria:

* adults

Where it's running

• Faculty of Medicine Pediatric Hematology Oncology Department
  Cairo, Egypt Recruiting
• Faculty of medicine ain shams university
  Cairo, Egypt Active not recruiting

Study contacts

• Study coordinator: Iman Ragab Prof of Pediatrics, Ain Shams University, Professor
• Email: hragab68@hotmail.com
• Phone: +20 1002550680

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Validation of the OHI Index for Hematologic Malignancies

  This study is testing a new index to see if it can help doctors better understand and predict outcomes for patients with blood cancers who might develop a serious condition called HLH.

  Recruiting at 2 sites Meir Medical Center · Kfar Saba and 1 other locations · NCT05882175

• Observing gut health in children with leukemia

  This study looks at how leukemia treatment affects gut health and recovery in children aged 0-16 to see if nutrition plays a role in their healing process.

  Recruiting Great Ormond Street Hospital for Children NHS Foundation Trust · London · NCT06899581

• Using CD45RA Depleted Stem Cells to Prevent Infections After Transplant

  This study is testing whether using special stem cells can help patients with high-risk leukemia recover their immune system faster and prevent infections after a stem cell transplant.

  Recruiting Phase 1/2 Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT06839456

• Using ruxolitinib with a modified HLH-94 regimen to treat hemophagocytic lymphohistiocytosis.

  This study is testing if a new combination of ruxolitinib and a modified treatment plan can help adults newly diagnosed with hemophagocytic lymphohistiocytosis feel better and live longer.

  Recruiting at 4 sites Phase 2 University of California, San Francisco · Irvine, California and 3 other locations · NCT06160791

• Understanding treatment outcomes in lymphoma-related hemophagocytic lymphohistiocytosis

  This study looks at how people with lymphoma who develop a serious condition called hemophagocytic lymphohistiocytosis are treated and what the outcomes are, to find better ways to help them survive.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT05898477

• Using Tadekinig Alfa to treat severe side effects from CAR T cell therapy

  This study is testing if a new drug called Tadekinig alfa can help people who have severe side effects from CAR T cell therapy feel better.

  Recruiting Early Phase 1 University of Pennsylvania · Philadelphia, Pennsylvania · NCT05306080

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.